Verquvo 5 mg (Vericiguat)
| Active Ingredient | Vericiguat |
|---|---|
| Indication: | Chronic heart failure |
| Manufacturer: | Bayer Zydus Pharma |
| Packaging | 14 Tablets in Strip |
| Strength | 5 mg |
Verquvo 5 mg contains Vericiguat, a medication used to treat chronic heart failure with reduced ejection fraction (HFrEF). It works by stimulating soluble guanylate cyclase (sGC), an enzyme that helps blood vessels relax and widen. This action reduces the strain on the heart, improves circulation, and lowers the risk of heart failure–related hospitalization or cardiovascular death. Verquvo is typically prescribed to patients who have recently experienced worsening heart failure. It is taken once daily with food. Common side effects may include low blood pressure, anemia, dizziness, and headache. Regular follow-up is important to monitor heart and blood pressure response.








There are no reviews yet.